Neurology · 2003 · 23 citations · 5 references
Life SciencesImmunologyNeurologyAutoimmunityExocytosisNeuroimmunologyAutoantibodiesAutoantigensAutoimmune DiseasesMultiple SclerosisSjogren SyndromeSjögren SyndromeAnti-ssa AntibodiesAnti-ssb AntibodiesCaspase CleavageCns AutoantibodiesDifferential Diagnosis CriteriaPrimary Sjögren SyndromeSjögren Syndrome DiagnosisTissue Autoantibodies
It is often difficult to diagnose Sjogren syndrome (SS) with neurologic manifestations as frequently only the nervous system is affected and anti-Ro (SSA) and anti-La (SSB) antibodies are found in fewer than 50% of cases.1,2⇓ In a recent study, we demonstrated that primary progressive multiple sclerosis (PPMS) should be the principal differential diagnosis for SS with CNS manifestations.2 However, the question remains as to whether SS is secondary to MS or whether the two are separate entities.3,4⇓ It was recently reported that antibodies against α-fodrin are both a sensitive and a specific marker for SS.5,6⇓ α-Fodrin is a cytoskeletal protein that binds to the cytoplasmic domains of a variety of molecules expressed on the cell surface. It is abundantly expressed in salivary glands but also other tissues including synapses and is probably involved in exocytosis. α-Fodrin is cleaved by caspase 3 upon apoptosis into …
5
Identification of α-Fodrin as a Candidate Autoantigen in Primary Sjögren's Syndrome
Norio Haneji, Takanori Nakamura, Koji Takio et al. · Science · 1997 · 405 citations
Life Sciences, Immunology, Pathology +14
The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis
de Sèze, David Devos, Giovanni Castelnovo et al. · Neurology · 2001 · 98 citations
Spontaneous resolution of idiopathic syringomyelia
Andreas Kastrup, Thomas Nägele, Helge Topka · Neurology · 2001 · 37 citations